Cybin Inc (CYBN)
0.341
0.00 (0.00%)
USD |
NYAM |
May 15, 16:00
0.341
0.00 (0.00%)
After-Hours: 16:00
Cybin Market Cap: 140.11M for May 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 14, 2024 | 140.44M |
| May 13, 2024 | 141.31M |
| May 10, 2024 | 148.95M |
| May 09, 2024 | 153.59M |
| May 08, 2024 | 152.03M |
| May 07, 2024 | 151.62M |
| May 06, 2024 | 151.21M |
| May 03, 2024 | 143.81M |
| May 02, 2024 | 143.81M |
| May 01, 2024 | 143.81M |
| April 30, 2024 | 143.81M |
| April 29, 2024 | 143.81M |
| April 26, 2024 | 143.81M |
| April 25, 2024 | 142.17M |
| April 24, 2024 | 145.87M |
| April 23, 2024 | 145.87M |
| April 22, 2024 | 148.09M |
| April 19, 2024 | 151.08M |
| April 18, 2024 | 151.99M |
| April 17, 2024 | 154.25M |
| April 16, 2024 | 155.97M |
| April 15, 2024 | 152.36M |
| April 12, 2024 | 150.39M |
| April 11, 2024 | 156.14M |
| April 10, 2024 | 164.36M |
| Date | Value |
|---|---|
| April 09, 2024 | 174.67M |
| April 08, 2024 | 178.74M |
| April 05, 2024 | 170.56M |
| April 04, 2024 | 174.22M |
| April 03, 2024 | 190.28M |
| April 02, 2024 | 172.41M |
| April 01, 2024 | 174.26M |
| March 28, 2024 | 169.90M |
| March 27, 2024 | 176.68M |
| March 26, 2024 | 176.35M |
| March 25, 2024 | 175.86M |
| March 22, 2024 | 171.51M |
| March 21, 2024 | 167.44M |
| March 20, 2024 | 172.57M |
| March 19, 2024 | 181.82M |
| March 18, 2024 | 184.90M |
| March 15, 2024 | 189.01M |
| March 14, 2024 | 176.27M |
| March 13, 2024 | 172.57M |
| March 12, 2024 | 180.79M |
| March 11, 2024 | 163.95M |
| March 08, 2024 | 160.45M |
| March 07, 2024 | 151.29M |
| March 06, 2024 | 131.24M |
| March 05, 2024 | 131.49M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
44.61M
Minimum
Jun 12 2023
515.21M
Maximum
Aug 03 2021
164.61M
Average
145.77M
Median
Market Cap Benchmarks
| Clearmind Medicine Inc | 4.207M |
| Acasti Pharma Inc | 25.19M |
| Aurinia Pharmaceuticals Inc | 760.15M |
| Edesa Biotech Inc | 14.30M |
| Lexaria Bioscience Corp | 39.56M |
Market Cap Related Metrics
| Price to Book Value | 1.533 |
| Price | 0.341 |
| Earnings Yield | -60.91% |